Metabolite systems profiling identifies exploitable weaknesses in retinoblastoma

Post navigation

Actionable Activating Oncogenic ERBB2/HER2 Transmembrane and Juxtamembrane Domain Mutations

A Computational Approach Identifies Immunogenic Features of Prognosis in Human Cancers

Signios Biosciences:
348 Hatch Drive Foster City, CA 94404, USA
Call us: +1 888-440-0954
Email us: info@signiosbio.com

Registered Office:
MedGenome Inc. 108 West 13th Street Wilmington, Delaware 19801, County of New Castle, USA

Stay ahead with exclusive insights, tips, and trends tailored for the multiomics and bioinformatics fields. Subscribe to our newsletter.